Your browser doesn't support javascript.
loading
Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer's disease.
Baker, Emily; Sims, Rebecca; Leonenko, Ganna; Frizzati, Aura; Harwood, Janet C; Grozeva, Detelina; Morgan, Kevin; Passmore, Peter; Holmes, Clive; Powell, John; Brayne, Carol; Gill, Michael; Mead, Simon; Bossù, Paola; Spalletta, Gianfranco; Goate, Alison M; Cruchaga, Carlos; Maier, Wolfgang; Heun, Reinhard; Jessen, Frank; Peters, Oliver; Dichgans, Martin; FröLich, Lutz; Ramirez, Alfredo; Jones, Lesley; Hardy, John; Ivanov, Dobril; Hill, Matthew; Holmans, Peter; Allen, Nicholas D; Morgan, B Paul; Seshadri, Sudha; Schellenberg, Gerard D; Amouyel, Philippe; Williams, Julie; Escott-Price, Valentina.
Afiliação
  • Baker E; Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.
  • Sims R; UK Dementia Research Institute at Cardiff University, Cardiff, United Kingdom.
  • Leonenko G; Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.
  • Frizzati A; Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.
  • Harwood JC; Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.
  • Grozeva D; Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.
  • Passmore P; Human Genetics, School of Life Sciences, Life Sciences Building A27, University Park, University of Nottingham, Nottingham, NG7 2RD, United Kingdom.
  • Holmes C; Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queens University, Belfast, United Kingdom.
  • Powell J; Division of Clinical Neurosciences, School of Medicine, University of Southampton, Southampton, United Kingdom.
  • Brayne C; Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, United Kingdom.
  • Gill M; Genetic Epidemiology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Mead S; Institute of Public Health, University of Cambridge, Cambridge, United Kingdom.
  • Bossù P; Mercer's Institute for Research on Ageing, St. James' Hospital, Dublin, Ireland.
  • Spalletta G; James Hospital and Trinity College, Dublin, Ireland.
  • Goate AM; MRC Prion Unit at UCL, Institute of Prion Diseases, London, United Kingdom.
  • Cruchaga C; Experimental Neuropsychobiology Laboratory, IRCCS Santa Lucia Foundation, Department of Clinical and Behavioral Neurology, Rome, Italy.
  • Maier W; Laboratory of Neuropsychiatry, IRCCS Santa Lucia Foundation, Rome, Italy.
  • Heun R; Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Jessen F; Hope Center Program on Protein Aggregation and Neurodegeneration, Washington University School of Medicine, St Louis, Missouri, United States of America.
  • Peters O; Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, United States of America.
  • Dichgans M; Hope Center Program on Protein Aggregation and Neurodegeneration, Washington University School of Medicine, St Louis, Missouri, United States of America.
  • FröLich L; German Centre for Neurodegenerative Diseases (DZNE), 53127 Bonn, Germany.
  • Ramirez A; Department of Psychiatry and Psychotherapy, University of Bonn, 53127, Bonn, Germany.
  • Jones L; German Centre for Neurodegenerative Diseases (DZNE), 53127 Bonn, Germany.
  • Hardy J; Department of Psychiatry and Psychotherapy, University of Cologne, 50937 Cologne, Germany.
  • Ivanov D; Department of Psychiatry and Psychotherapy, Charité Berlin, Berlin, Germany.
  • Hill M; German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
  • Holmans P; Institute for Stroke and Dementia Research, Klinikum der Universität München, Munich, Germany.
  • Allen ND; German Center for Neurodegenerative Diseases (DZNE, Munich), Munich, 80336, Germany.
  • Morgan BP; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
  • Seshadri S; Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany.
  • Schellenberg GD; Department of Psychiatry and Psychotherapy, University of Cologne, 50937 Cologne, Germany.
  • Amouyel P; Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
  • Williams J; Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.
  • Escott-Price V; Department of Molecular Neuroscience, UCL, Institute of Neurology, London, United Kingdom.
PLoS One ; 14(7): e0218111, 2019.
Article em En | MEDLINE | ID: mdl-31283791
ABSTRACT
Late onset Alzheimer's disease is the most common form of dementia for which about 30 susceptibility loci have been reported. The aim of the current study is to identify novel genes associated with Alzheimer's disease using the largest up-to-date reference single nucleotide polymorphism (SNP) panel, the most accurate imputation software and a novel gene-based analysis approach which tests for patterns of association within genes, in the powerful genome-wide association dataset of the International Genomics of Alzheimer's Project Consortium, comprising over 7 million genotypes from 17,008 Alzheimer's cases and 37,154 controls. In addition to earlier reported genes, we detected three novel gene-wide significant loci PPARGC1A (p = 2.2 × 10-6), RORA (p = 7.4 × 10-7) and ZNF423 (p = 2.1 × 10-6). PPARGC1A and RORA are involved in circadian rhythm; circadian disturbances are one of the earliest symptoms of Alzheimer's disease. PPARGC1A is additionally linked to energy metabolism and the generation of amyloid beta plaques. RORA is involved in a variety of functions apart from circadian rhythm, such as cholesterol metabolism and inflammation. The ZNF423 gene resides in an Alzheimer's disease-specific protein network and is likely involved with centrosomes and DNA damage repair.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas / Genoma Humano / Polimorfismo de Nucleotídeo Único / Membro 1 do Grupo F da Subfamília 1 de Receptores Nucleares / Doença de Alzheimer / Coativador 1-alfa do Receptor gama Ativado por Proliferador de Peroxissomo Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas / Genoma Humano / Polimorfismo de Nucleotídeo Único / Membro 1 do Grupo F da Subfamília 1 de Receptores Nucleares / Doença de Alzheimer / Coativador 1-alfa do Receptor gama Ativado por Proliferador de Peroxissomo Idioma: En Ano de publicação: 2019 Tipo de documento: Article